NCT04696081

Atrial Fibrillation in Active Cancer Patients

Multicenter International Prospective Registry to Identify Major Cardiovascular Events Associated With the Occurrence of Atrial Fibrillation in Active Cancer Patients

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (estimated)
• Sponsor: University Hospital, Caen · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Atrial fibrillation is a common complication of both cancer and anticancer drugs but the consequences of such events remain poorly known and are not adressed in both phase III oncological trials and cardiological guidelines. The objective of this study is to create a prospective multicenter international registry of adult patients with an active cancer and experiencing atrial fibrillation to study major cardiovascular events occurrence during a 1 year follow-up.

Conditions

• Cancer
• Drug Toxicity
• Atrial Fibrillation
• Cardiovascular Complication

Interventions

Type	Name	Description
OTHER	occurence of atrial fibrillation	all adult patients with an active cancer and experiencing atrial fibrillation will be consecutively include. Active cancers will be defined according Agnelli et al. (NEJM 2020; 382:1599-1607).

Timeline

• Start date: 2021-09-01
• Primary completion: 2025-09-01
• Completion: 2026-01-01
• First posted: 2021-01-06
• Last updated: 2024-08-09

Locations

1 site across 1 country: France